Caribou Biosciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Caribou Biosciences Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Berkeley
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CRBU
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001619856
EIN
45-3728228

Board of directors

Chief executives

Rachel E. Haurwitz · President and CEO
Dates unknown

Board connections

2 of this board's directors also sit on 2 other boards. 1 is in the same sector.

Network of Caribou Biosciences Inc.'s board connections Boundless Bio Inc. Boundless Bio Inc. Seer Inc. Seer Inc. Nancy Whiting Nancy Whiting Rachel E. Haurwitz Rachel E. Haurwitz Caribou Biosciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$47,474
5 sales by 4 insiders
Date Insider Transaction Shares Price Value
Feb 25, 2026 Kelly Timothy P Officer (Chief Technology Officer) Open-market sale −6,228 $1.93 $12,020
Feb 24, 2026 Kelly Timothy P Officer (Chief Technology Officer) Open-market sale −3,147 $1.96 $6,168
Feb 24, 2026 MCCLUNG BARBARA G Officer (Chief Legal Officer) Open-market sale −6,938 $1.96 $13,598
Feb 24, 2026 Khan Ruhi Ahmad Officer (Chief Business Officer) Open-market sale −6,938 $1.96 $13,598
Feb 24, 2026 Albertson Tina M. Officer (Chief Medical Officer) Open-market sale −1,066 $1.96 $2,089
Feb 20, 2026 Kelly Timothy P Officer (Chief Technology Officer) Grant or award +45,000 — —
Feb 20, 2026 MCCLUNG BARBARA G Officer (Chief Legal Officer) Grant or award +45,000 — —
Feb 20, 2026 Khan Ruhi Ahmad Officer (Chief Business Officer) Grant or award +45,000 — —
Feb 20, 2026 Albertson Tina M. Officer (Chief Medical Officer) Grant or award +55,000 — —
Feb 20, 2026 Ryali Sriram Officer (Chief Financial Officer) Grant or award +55,000 — —
Feb 20, 2026 Rachel E. Haurwitz Director, Officer (President and CEO) Grant or award +151,700 — —
Mar 14, 2025 Rachel E. Haurwitz Director, Officer (President and CEO) Open-market purchase +20,000 $1.02 $20,400
Feb 21, 2025 MCCLUNG BARBARA G Officer (Chief Legal Officer) Open-market sale −3,564 $1.35 $4,811
Feb 21, 2025 Khan Ruhi Ahmad Officer (Chief Business Officer) Open-market sale −3,564 $1.35 $4,811
Feb 21, 2025 Kanner Steven Officer (Chief Scientific Officer) Open-market sale −3,564 $1.35 $4,811

Organizations in the same sector, closest in location and size first.

Questions about Caribou Biosciences Inc.

Who is the CEO of Caribou Biosciences Inc.?

Rachel E. Haurwitz is Caribou Biosciences Inc.'s President and CEO.

How many directors are on Caribou Biosciences Inc.'s board?

Caribou Biosciences Inc.'s board has 8 directors: Andrew Guggenhime, Dara Richardson-Heron, David Lee Johnson, Nancy Whiting, Natalie Sacks, Rachel E. Haurwitz, Ran Zheng and Scott Braunstein.

Are Caribou Biosciences Inc. insiders buying or selling shares?

Over the last 12 months, Caribou Biosciences Inc. insiders made no open-market purchases and sold $47,474 of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="caribou-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.